EJMK Ventures’s Gilead Sciences GILD Stock Holding History

EJMK Ventures’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$224K	Buy	+1,505	New	+$211K	0.09%	150

Other funds holding GILD

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $127B AUM 33.25% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $313B AUM 26.62% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

EJMK Ventures's GILD Position: Q3 2026 in Review

EJMK Ventures opened a new position in Gilead Sciences (GILD) in Q3 2026: 1,505 shares worth $224K. The stake represents 0.09% of the portfolio and ranks #150 among its holdings.

1,477 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

EJMK Ventures held 1,505 shares of Gilead Sciences worth $224K as of Q3 2026.
Gilead Sciences was a new EJMK Ventures position in Q3 2026.
Gilead Sciences made up 0.09% of EJMK Ventures's portfolio in Q3 2026, its #150 holding.
1,477 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on EJMK Ventures's 13F filing for Q3 2026, filed 21 Oct 2026.